Eli Lilly and Co

Eli Lilly investors spooked by weak Mounjaro sales, but it’s the obesity drug approval that will unlock its value
The demand is there, but so are the hurdles. Eli Lilly investors got a reality check on Thursday, as the stock tumbled more than 6%. Hopes have been running high for the company’s recently launched Mounjaro. Right now, the drug has been approved to treat type 2 diabetes, but many expect sales to really take […]
Read More
Stocks making the biggest moves midday: Netflix, Coinbase, Alphabet, SVB Financial & more
Tech stocks on display at the Nasdaq. Peter Kramer | CNBC Check out the companies making headlines in midday trading. Netflix — Shares of the streaming giant jumped more than 6% after Netflix added 7.66 million net subscribers in the fourth quarter, above the 4.57 million expected, according to StreetAccount. Founder Reed Hastings also announced […]
Read More
Shares earning the biggest moves premarket: Netflix, Alphabet, Nordstrom, PagerDuty and far more
A indicator is posted in front of a Google place of work on April 26, 2022 in San Francisco, California. Google guardian company Alphabet will report initial quarter earnings right now following the closing bell. Justin Sullivan | Getty Images Information | Getty Images Test out the firms earning headlines in advance of the bell: […]
Read More
Here’s where to look for the next developments in the fight against Alzheimer’s disease
Biogen and its partner, Japanese drugmaker Eisai , earlier this month received accelerated approval from the Food and Drug Administration for Leqembi, a monoclonal antibody to treat Alzheimer’s disease. Although Biogen shares are trading higher in the wake of this development , they are only up 4% or so year to date. To some degree, […]
Read More
Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant looks to advance drugs in its stellar pipeline. Executives detailed reasons for optimism at a major industry gathering this week. “We’re looking at another unprecedented year for Lilly,” CFO Anat Ashkenazi said Tuesday night at JPMorgan’s annual health-care conference. “A strong year […]
Read More
Biden administration will select first 10 drugs for Medicare price negotiations by September
The Health and Human Services Department plans to publish in September a list of 10 drugs covered by Medicare that it will target for price negotiations, the first phase in a long awaited effort to cut costs for seniors. HHS officials, in a call with reporters on Wednesday, laid out the federal government’s road map […]
Read More
Jim Cramer’s Investing Club meeting Tuesday: Microsoft, health care, Emerson Electric
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Reduce exposure to tech Watch for health care buying opportunity Eyeing an industrial play 1. Reduce exposure to tech Stocks inched up on Tuesday, with the Nasdaq Composite rising 0.22% […]
Read More